Patents by Inventor Asher Maymon

Asher Maymon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8129173
    Abstract: Provided is a method of selectively enzymatically esterifying or selectively enzymatically solvolyzing epimers of analogs of vitamin D having a stereogenic center at C-24 that has a free or esterified OH group. The metod can be used, for example, for separating mixed epimers of the vitamin D analog.
    Type: Grant
    Filed: January 9, 2003
    Date of Patent: March 6, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Shapiro, Ayelet Fishman, Reinhard Effenberger, Asher Maymon, Anchel Schwartz
  • Patent number: 7205420
    Abstract: Provided is a method of general applicability of epimerizing a vitamin-D analog having an asymmetric allylic carbon atom at the C-24 position. The method is of particular utility in making calcipotriene.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: April 17, 2007
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Shapiro, Reinhard Effenberger, Asher Maymon, Anchel Schwartz
  • Publication number: 20070066846
    Abstract: The invention encompasses processes for the synthesis of (S)-Pregabalin, (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid.
    Type: Application
    Filed: April 11, 2006
    Publication date: March 22, 2007
    Inventors: Asher Maymon, Vinod Kansal, Lilach Hedvati
  • Publication number: 20040054204
    Abstract: Provided is a method of general applicability of epimerizing a vitamin-D analog having an asymmetric allylic carbon atom at the C-24 position. The method is of particular utility in making calcipotriene.
    Type: Application
    Filed: June 11, 2003
    Publication date: March 18, 2004
    Inventors: Evgeny Shapiro, Reinhard Effenberger, Asher Maymon, Anchel Schwartz
  • Publication number: 20030166226
    Abstract: Provided is a method of selectively enzymatically esterifying or selectively enzymatically solvolyzing epimers of analogs of vitamin D having a stereogenic center at C-24 that has a free or esterified OH group. The metod can be used, for example, for separating mixed epimers of the vitamin D analog.
    Type: Application
    Filed: January 9, 2003
    Publication date: September 4, 2003
    Inventors: Evgeny Shapiro, Ayelet Fishman, Reinhard Effenberger, Asher Maymon, Anchel Schwartz
  • Publication number: 20020107275
    Abstract: The present invention provides novel ondansetron hydrochloride crystalline polymorphic forms and solvates. Processes for making and interconverting the polymorphic forms are also provided. Further provided are pharmaceutical compositions and therapeutic methods using the novel polymorphic forms and hydrates.
    Type: Application
    Filed: October 30, 2001
    Publication date: August 8, 2002
    Inventors: Ramy Lidor-Hadas, Judith Aronhime, Revital Lifshitz, Shlomit Weizel, Valerie Niddam, Asher Maymon